NEW YORK, Nov. 9 (GenomeWeb News) - Shares in CombiMatrix were down 5.9 percent, or $.12, at $1.91 in mid-afternoon trading after gaining 5.1 percent yesterday on news that it was part of an alliance aimed at monitoring vaccine production.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetic analysis of pollutant-tolerant fish, and more.
Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.
New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.
NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.